June 1, 2024
Signed a joint research agreement with Department of Chemistry, Faculty of Medicine, Keio University.
ファルストマ株式会社
代表取締役CEO
久保田雅彦
(Head Office: Tokyo; President: Masahiko Kubota) and Department of Chemistry, Faculty of Medicine, Keio University (Principal Investigator: Associate Professor Mari Kubota) have signed a joint research agreement to realize an oral insulin drug using UFB (Ultra Fine Bubble) water.
Based on this joint research agreement, in vitro and in vivo studies will be conducted to elucidate the interaction between UFB and insulin, leading to non-clinical studies and pharmacokinetic evaluation.
We look forward to your continued support and guidance.
Farstoma Inc
Contact us for more information .